14-64523010-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001123329.2(ZBTB1):āc.1506T>Gā(p.Asp502Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,614,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001123329.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251434Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135890
GnomAD4 exome AF: 0.000131 AC: 191AN: 1461876Hom.: 0 Cov.: 33 AF XY: 0.000136 AC XY: 99AN XY: 727234
GnomAD4 genome AF: 0.000125 AC: 19AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2024 | The c.1506T>G (p.D502E) alteration is located in exon 2 (coding exon 1) of the ZBTB1 gene. This alteration results from a T to G substitution at nucleotide position 1506, causing the aspartic acid (D) at amino acid position 502 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at